Piroxicam Premedication for Postendodontic Pain in Non-vital Mandibular Molars

• Status: Unknown status
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study is to evaluate the effect of piroxicam (20mg) compared to placebo on post-endodontic pain of single-visit endodontic treatment of non-vital mandibular molars.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Piroxicam

Criteria

Inclusion Criteria:

1. Patients aging between 18-50 years old

2. Patients with mandibular molar with non-vital pulp.

3. Systemically- healthy patients (ASA I or II).

4. Patients who agree to attend for recall appointments and provide a written consent.

Exclusion Criteria:

1. Pregnant or lactating female patients.

2. Patients allergic to piroxicam.

3. History of peptic ulceration.

4. Periapical abscess, fistula.

5. Non-restorable teeth.

6. Moderate or severe marginal periodontitis i.e. pocket probe>3mm.